EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: EBITDA for 2022 above the forecast range on the basis of preliminary figures

In the course of preparing the consolidated financial statements for the past financial year, the Management Board of RHÖN-KLINIKUM Aktiengesellschaft now assumes that the Group's earnings before interest, taxes, depreciation and amortisation (EBITDA) will be above the forecast published by the company in March 2022 (EBITDA value between EUR 92 million and EUR 102 million). Based on preliminary and unaudited figures, the Management Board currently estimates that the Group's EBITDA will be in a range between EUR 103 million and EUR 109 million.

The Annual Report 2022 and further information on the past financial year will be published on 30 March 2023.
Contact:
Julian Schmitt
Head of Investor Relations & Treasury
+49 9771 65 12250